in a bacteriologic and clinical assessment of nalidixic acid ( neggram ) , 95 % of gramnegative urinary pathogens tested in vitro ( with the exception of pseudomonas pyocyanea ) were sensitive to therapeutically attainable levels .
C0027353
nalidixic acid
C0722010
neggram